Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Market Commentary

| More

Modi government may insist on giving priority to generics: Angel Broking

Posted On: 2017-04-18 20:23:52

Views of Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking):

The Modi government may pass a new law making it compulsory for doctors to prescribe only generic drugs. This is part of the effort of the current government to make healthcare more affordable to larger sections of the Indian population. Generics are the pharmaceutical combinations without the brand backing of a big international name. Currently, generic drugs already account for 80%of the Indian market and is expected to go up further to 90% by 2020.

However, there could be some practical problems to this announcement. If the doctor only prescribes the generic name, it will be left to the chemist to decide which particular brand to push. So the marketing focus of pharma companies will now have to shift from the doctor to the chemist. Most pharma experts believe that this change may be feasible in government hospitals but not on a pan-India basis. The last time the government had attempted something similar was under the Ajanta government in 1978. At that time, the idea had to be shelved after the pharma industry challenged the order in Court. Though, not yet fully out, in terms of policy, it definitely means that the pricing pressure on the Industry is here to stay. Overall logistics and implementation could be the key!


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Stay long, 9300 to act as a sheet anchor for the day: Angel Broking
4QFY17 results: Different sectors, different reactions
Strategy: Spring is in the multiples, not earnings (as yet) - Kotak
Economy: State budgets: Walking the tight rope - Kotak
Strategy: He has both aptitude and attitude issues - Kotak
Political stability and strong macros take markets to new highs: Angel Broking
Option data indicates expiry above 9350: Angel Broking
Key Takeaways from the SEBI April 26th Board Meet: Angel Broking
Long build-up seen for the first time in April series, Nifty may resume its uptrend: Angel Broking
BankNifty gearing up for new highs: Angel Broking
Optimism back on the street, Nifty gearing up for new highs: Angel Broking
9200 seems strong hurdle for April series: Angel Broking
France to witness the next revolution with Presidency Elections: Angel Broking
Banking, metal & reality stocks to keep in focus for week ahead: Epic Research
Economy: MPC minutes: Hint of contrasting views - Kotak
Nifty stuck in a tight range, focus on individual stocks: Angel Broking
Economy: Near-normal monsoon on the cards - Kotak
Stay light and keep a track of key levels: Angel Broking
FIIs refrained from shorting in today's correction: Angel Broking
Economy: FRBM report: Nub lies in implementation - Kotak
Liquidity conditions to tighten this week - Kotak
9130 - 9050 to provide a rock solid support, use dips to buy: Angel Broking
No signs of reversal in F&O segment, buy on dips: Angel Broking
Strong Rupee should keep WPI inflation under check going ahead: Angel Broking
Index below 9172, but still 9100 seems to be a sheet anchor: Angel Broking
Economy: Inflation firms up, production disappoints - Kotak
Strategy: The bogus argument of 'liquidity' - Kotak
Market may see further pressure on IT stocks and Metals stocks: Epic Research
Market indices to remain traded on the choppy note: Amrapali Aadya Trading & Investments
No meaningful change in derivative data despite recent corrective move: Angel Broking
Weekly Market Outlook - Mr. Dipen Shah, Sr. Vice President - PCG Research at Kotak Securities Limited
A fresh buying from FII's may lead to resumption of the upward rally: Angel Broking
Once again hourly '89 EMA' became the savior, Hold longs until it remains unbroken: Angel Broking
Macro numbers - Upasna Bhardwaj, Sr. Economist, Kotak Mahindra Bank
Government released fine print of the FRBM Report: Angel Broking
Market reluctant to fall, trade with a positive bias and focus on individual stocks: Angel Broking
French Elections to sway Euro's direction in April'17: Angel Broking
Option data indicating optimism to continue: Angel Broking
Angel Broking - The Market resilience continues..
Nifty approaching strong support zone 9160 - 9120, looks for buying opportunities around it: Angel Broking
Metals, Banks and IT may see further dip due to profit booking : Epic Research
Investors to look for the entry in the infrastructure and reality stocks: Amrapali Aadya Trading & Investments
Geo-political concern led to some profit booking: Angel Broking
Do not get carried away by such corrective moves, 9160 - 9114 to provide a decent support now: Angel Broking
RBI is still in wait and watch mode post demonetization, rates remain unchanged : Epic Research
RBI Policy Reaction - Radhika Rao, India Economist, DBS Bank
View on Monetary Policy - Suvodeep Rakshit - Sr. Economist - Kotak Institutional Equities
RBI OFFERS MULTIPLE INDISCERNIBLE PLUSSES
Real Estate : Reaction on RBI's bi-monthly monitoring Policy Review Meeting
Markets shrugged off global cues, 9230 - 9200 remains to be a strong support zone: Angel Broking


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017